Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Epitope prediction by novel immunoinformatics approach: a state-of-the-art review
Immunoinformatics is a science that helps to create significant immunological information
using bioinformatics softwares and applications. One of the most important applications of …
using bioinformatics softwares and applications. One of the most important applications of …
Contribution of anoctamins to cell survival and cell death
K Kunzelmann, J Ousingsawat, R Benedetto, I Cabrita… - Cancers, 2019 - mdpi.com
Before anoctamins (TMEM16 proteins) were identified as a family of Ca2+-activated chloride
channels and phospholipid scramblases, the founding member anoctamin 1 (ANO1 …
channels and phospholipid scramblases, the founding member anoctamin 1 (ANO1 …
Dendritic cell/cytokine‐induced killer cell‐based immunotherapy in lung cancer: what we know and future landscape
M Mohsenzadegan, RW Peng… - Journal of cellular …, 2020 - Wiley Online Library
Multiple modalities for lung cancer therapy have emerged in the past decade, whereas their
clinical applications and survival‐beneficiary is little known. Vaccination with dendritic cells …
clinical applications and survival‐beneficiary is little known. Vaccination with dendritic cells …
A Pore Idea: the ion conduction pathway of TMEM16/ANO proteins is composed partly of lipid
Since their first descriptions, ion channels have been conceived as proteinaceous conduits
that facilitate the passage of ionic cargo between segregated environments. This concept is …
that facilitate the passage of ionic cargo between segregated environments. This concept is …
Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
Melanoma antigen gene (MAGE)-A6 and MAGE-A11 are two of the most cancer-testis
antigens overexpressed in various types of cancers. However, the clinical and prognosis …
antigens overexpressed in various types of cancers. However, the clinical and prognosis …
ANO7 African-ancestral genomic diversity and advanced prostate cancer
J Jiang, PXY Soh, SBA Mutambirwa… - Prostate cancer and …, 2024 - nature.com
Abstract Background Prostate cancer (PCa) is a significant health burden for African men,
with mortality rates more than double global averages. The prostate specific Anoctamin 7 …
with mortality rates more than double global averages. The prostate specific Anoctamin 7 …
Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable …
Abstract Purpose Cancer testis antigens (CTAs) are a family of proteins typically expressed
in male testicles but overexpressed in various cancer cell types. Transmembrane …
in male testicles but overexpressed in various cancer cell types. Transmembrane …
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
A Marx, L Koopmann, D Höflmayer… - Cancer biology & …, 2021 - cancerbiomed.org
Objective: Anoctamin 7 (ANO7) is a calcium 2+-dependent chloride ion channel protein. Its
expression is restricted to prostate epithelial cells. The exact function is unknown. This study …
expression is restricted to prostate epithelial cells. The exact function is unknown. This study …
A review of preclinical experiments toward targeting M2 macrophages in prostate cancer
Prostate cancer is malignant cancer leading to high mortality in the male population. The
existence of suppressive cells referred to as tumor-associated macrophages (TAM) is a …
existence of suppressive cells referred to as tumor-associated macrophages (TAM) is a …
Co‐expression of TLR‐9 and MMP‐13 is associated with the degree of tumour differentiation in prostate cancer
In vitro experiments demonstrated that stimulation of Toll‐like receptor 9 (TLR‐9) by
synthetic TLR‐9 ligands induces the invasion of TLR‐9‐expressing prostate cancer cells …
synthetic TLR‐9 ligands induces the invasion of TLR‐9‐expressing prostate cancer cells …